Omnicell ROA 2010-2024 | OMCL
Current and historical return on assets (ROA) values for Omnicell (OMCL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Omnicell ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
2024-09-30 |
$-0.02B |
$2.30B |
-0.75% |
2024-06-30 |
$-0.02B |
$2.29B |
-0.89% |
2024-03-31 |
$-0.02B |
$2.28B |
-0.94% |
2023-12-31 |
$-0.02B |
$2.23B |
-0.90% |
2023-09-30 |
$-0.03B |
$2.22B |
-1.53% |
2023-06-30 |
$-0.02B |
$2.19B |
-1.04% |
2023-03-31 |
$-0.02B |
$2.25B |
-0.78% |
2022-12-31 |
$0.01B |
$2.21B |
0.28% |
2022-09-30 |
$0.05B |
$2.18B |
2.24% |
2022-06-30 |
$0.06B |
$2.13B |
2.84% |
2022-03-31 |
$0.07B |
$2.12B |
3.43% |
2021-12-31 |
$0.08B |
$2.14B |
3.83% |
2021-09-30 |
$0.08B |
$2.05B |
4.09% |
2021-06-30 |
$0.06B |
$1.96B |
3.19% |
2021-03-31 |
$0.04B |
$1.89B |
2.10% |
2020-12-31 |
$0.03B |
$1.83B |
2.13% |
2020-09-30 |
$0.04B |
$1.72B |
2.81% |
2020-06-30 |
$0.05B |
$1.22B |
3.97% |
2020-03-31 |
$0.07B |
$1.23B |
5.62% |
2019-12-31 |
$0.06B |
$1.24B |
5.02% |
2019-09-30 |
$0.05B |
$1.24B |
4.60% |
2019-06-30 |
$0.05B |
$1.20B |
4.26% |
2019-03-31 |
$0.04B |
$1.18B |
3.60% |
2018-12-31 |
$0.04B |
$1.08B |
3.71% |
2018-09-30 |
$0.06B |
$1.05B |
5.32% |
2018-06-30 |
$0.05B |
$1.03B |
4.89% |
2018-03-31 |
$0.04B |
$1.04B |
4.52% |
2017-12-31 |
$0.03B |
$1.02B |
3.30% |
2017-09-30 |
$0.01B |
$0.92B |
0.98% |
2017-06-30 |
$0.00B |
$0.91B |
0.33% |
2017-03-31 |
$-0.00B |
$0.91B |
0.00% |
2016-12-31 |
$0.01B |
$0.94B |
1.08% |
2016-09-30 |
$0.01B |
$0.93B |
1.08% |
2016-06-30 |
$0.02B |
$0.91B |
2.00% |
2016-03-31 |
$0.03B |
$0.92B |
3.73% |
2015-12-31 |
$0.03B |
$0.58B |
5.33% |
2015-09-30 |
$0.03B |
$0.58B |
5.54% |
2015-06-30 |
$0.03B |
$0.60B |
5.44% |
2015-03-31 |
$0.03B |
$0.57B |
5.42% |
2014-12-31 |
$0.03B |
$0.56B |
5.57% |
2014-09-30 |
$0.03B |
$0.55B |
5.37% |
2014-06-30 |
$0.03B |
$0.54B |
5.67% |
2014-03-31 |
$0.03B |
$0.51B |
5.45% |
2013-12-31 |
$0.02B |
$0.49B |
4.98% |
2013-09-30 |
$0.02B |
$0.51B |
4.90% |
2013-06-30 |
$0.02B |
$0.47B |
4.91% |
2013-03-31 |
$0.02B |
$0.46B |
3.94% |
2012-12-31 |
$0.02B |
$0.44B |
3.90% |
2012-09-30 |
$0.01B |
$0.42B |
3.58% |
2012-06-30 |
$0.01B |
$0.41B |
2.66% |
2012-03-31 |
$0.01B |
$0.37B |
3.32% |
2011-12-31 |
$0.01B |
$0.36B |
3.11% |
2011-09-30 |
$0.01B |
$0.36B |
2.29% |
2011-06-30 |
$0.01B |
$0.35B |
1.74% |
2011-03-31 |
$0.01B |
$0.35B |
1.47% |
2010-12-31 |
$0.01B |
$0.34B |
1.48% |
2010-09-30 |
$0.01B |
$0.34B |
1.51% |
2010-06-30 |
$0.01B |
$0.33B |
1.53% |
2010-03-31 |
$0.00B |
$0.33B |
1.24% |
2009-12-31 |
$0.00B |
$0.32B |
0.32% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$2.264B |
$1.147B |
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|